Skip to main content
. 2019 Sep 20;10:1050. doi: 10.3389/fphar.2019.01050

Figure 8.

Figure 8

Principal component distributions from aMD simulations. (A) FLT3-WT + quizartinib; (B) FLT3-F691L + quizartinib; (C) FLT3-WT + PLX3397; (D) FLT3-F691L + PLX3397.